In the rapidly evolving bioanalytical testing landscape, the need for high-throughput and reliable serological assays has underscored significant challenges in data management and regulatory compliance. The amount of data generated by an automated platform presents unique challenges in the regulated environment, as it is key to ensure that samples can be accurately and rapidly traced throughout the workstream. The Data Collection and Reporting Platform (DCARP) was developed to address these challenges, providing a robust solution for bioanalytical testing labs seeking to integrate robotic automation with data automation.
DCARP tackles critical issues faced by regulated laboratories by seamlessly integrating data from various platforms and presenting it to scientists in an accessible format that allows rapid decision making. Its comprehensive traceability features meticulous sample tracking, including origin, lineage, and processing steps, ensuring complete transparency.
Moreover, DCARP maintains a detailed ledger of sample transactions, ensuring compliance with regulatory standards and facilitating evidence provision to Regulatory Authorities. By automating data ingestion and processing, DCARP significantly reduces manual intervention, streamlining workflows and increasing overall efficiency. Collectively these improvements allow generation of data that allows more rapid development of vaccines to meet unmet medical needs.
DCARP tackles critical issues faced by regulated laboratories by seamlessly integrating data from various platforms and presenting it to scientists in an accessible format that allows rapid decision making. Its comprehensive traceability features meticulous sample tracking, including origin, lineage, and processing steps, ensuring complete transparency.
Moreover, DCARP maintains a detailed ledger of sample transactions, ensuring compliance with regulatory standards and facilitating evidence provision to Regulatory Authorities. By automating data ingestion and processing, DCARP significantly reduces manual intervention, streamlining workflows and increasing overall efficiency. Collectively these improvements allow generation of data that allows more rapid development of vaccines to meet unmet medical needs.
Session type
Schedule
Name
Revolutionizing Regulated Bioanalytical Testing with Robotic Automation
Speakers
Time
-
Tracks
On